-
EP1871350
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1871350
| EP1871350 - METHODS OF INCREASING NATURAL KILLER CELL ACTIVITY FOR THERAPY [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 08.04.2011 Database last updated on 14.11.2024 | Most recent event Tooltip | 08.04.2011 | Application deemed to be withdrawn | published on 11.05.2011 [2011/19] | Applicant(s) | For all designated states Synta Pharmaceuticals Corporation 45 Hartwell Avenue Lexington, MA 02421 / US | [2008/01] | Inventor(s) | 01 /
BARSOUM, James 6 Moreland Avenue Lexington, Massachusetts 02421 / US | 02 /
DU, Zhenjian 18 Overlock Drive Northborough, Massachusetts 01532 / US | [2008/01] | Representative(s) | Snodin, Michael D. Potter Clarkson LLP The Belgrave Centre Talbot Street Nottingham NG1 5GG / GB | [N/P] |
| Former [2008/01] | Snodin, Michael D. Eric Potter Clarkson LLP Park View House 58 The Ropewalk Nottingham NG1 5DD / GB | Application number, filing date | 06750374.8 | 13.04.2006 | [2008/01] | WO2006US14320 | Priority number, date | US20050671910P | 15.04.2005 Original published format: US 671910 P | [2008/01] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2006113572 | Date: | 26.10.2006 | Language: | EN | [2006/43] | Type: | A1 Application with search report | No.: | EP1871350 | Date: | 02.01.2008 | Language: | EN | The application published by WIPO in one of the EPO official languages on 26.10.2006 takes the place of the publication of the European patent application. | [2008/01] | Search report(s) | International search report - published on: | EP | 26.10.2006 | Classification | IPC: | A61K31/16, A61K31/165, A61P37/04 | [2008/01] | CPC: |
A61K31/165 (EP,US);
A61K31/16 (EP,US);
A61P11/00 (EP);
A61P13/02 (EP);
A61P31/00 (EP);
A61P31/04 (EP);
A61P31/10 (EP);
A61P31/12 (EP);
A61P33/04 (EP);
A61P33/10 (EP);
A61P33/12 (EP);
A61P37/04 (EP);
Y02A50/30 (EP,US)
(-)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2008/01] | Extension states | AL | 01.11.2007 | BA | 01.11.2007 | HR | 01.11.2007 | MK | 01.11.2007 | YU | 01.11.2007 | Title | German: | VERFAHREN ZUR ERHÖHUNG DER NATÜRLICHEN KILLERZELL-AKTIVITÄT ZUR THERAPIE | [2008/01] | English: | METHODS OF INCREASING NATURAL KILLER CELL ACTIVITY FOR THERAPY | [2008/01] | French: | METHODES D'ACCROISSEMENT DE L'ACTIVITE DES CELLULES TUEUSES NATURELLES A DES FINS THERAPEUTIQUES | [2008/01] | Entry into regional phase | 01.11.2007 | National basic fee paid | 01.11.2007 | Designation fee(s) paid | 01.11.2007 | Examination fee paid | Examination procedure | 13.02.2007 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 26.10.2007 | Amendment by applicant (claims and/or description) | 01.11.2007 | Examination requested [2008/01] | 02.11.2010 | Application deemed to be withdrawn, date of legal effect [2011/19] | 09.12.2010 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2011/19] | Fees paid | Renewal fee | 27.03.2008 | Renewal fee patent year 03 | 29.04.2009 | Renewal fee patent year 04 | Penalty fee | Additional fee for renewal fee | 30.04.2010 | 05 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]WO03047524 (DANA FARBER CANCER INST INC [US], et al) [Y] 1-30 * page 42, lines 4-11 *; | [Y]WO03006428 (SBR PHARMACEUTICALS CORP [US], et al) [Y] 1-30 * claim 1 *; | [Y]WO2004064826 (SYNTA PHARMACEUTICALS CORP [US], et al) [Y] 1-30 * claim 1 *; | [PX]WO2006033913 (SYNTA PHARMACEUTICALS CORP [US], et al) [PX] 1-30 * page 19, lines 20-26 *; | [E]WO2006055747 (SYNTA PHARMACEUTICALS CORP [US], et al) [E] 1-6,28-30 * page 18, lines 20-22 *; | [E]WO2006062732 (SYNTA PHARMACEUTICALS CORP [US], et al) [E] 1-6,28-30 * page 44, lines 9-17 * |